Nasal Immune Challenge Study

NCT06021002 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Innate Inflammatory Response
Asthma
Nasal Allergy

Interventions

DRUG: R848
DRUG: Saline

Sponsor

Cambridge University Hospitals NHS Foundation Trust